InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by Krishnan Suma, President, R&D. Insider active across 1 companies, notably Krystal Biotech, Inc.. Aggregated, 5 filings have been recorded. Total volume traded: €12.7m. The latest transaction was disclosed on 4 March 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
US$90,188407 shares@ US$221.59250.0013% mcap1.4% of flow
Common Stock
SEC:0001298711-26-000004·
€90,188407 shares@ €221.59250.0013% mcap0.7% of flow
Common Stock
SEC:0001298711-26-000004:0·
€183,3003,282 shares@ €55.850.0025% mcap1.4% of flow
Common Stock
SEC:0001298711-22-000003:0·
€6m100,000 shares@ €62.42630.087% mcap98.6% of flow
Common Stock
SEC:0000899243-21-048125·
€6m100,000 shares@ €62.42630.087% mcap48.6% of flow
Common Stock
SEC:0000899243-21-048125:0·
5 of 5 declarations
About Krishnan Suma
Suma Krishnan is the President and Head of Research and Development at Krystal Biotech, Inc. She leads the company's research and innovation efforts, focusing on the development of new therapies. With deep expertise in the biopharmaceutical field, Suma Krishnan plays a crucial role in advancing medical treatments. Her leadership is essential for Krystal Biotech, Inc.'s growth strategy.
